InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Explore the complete record of transactions filed by HULL CHARLES W, Dirigeant. Officer active across 1 companies, notably 3D SYSTEMS CORP. Cumulatively, 9 disclosures have been published. Total volume traded: €449k. The latest transaction was filed on 8 June 2022 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations9 total
€269,46426,386 shares@ €10.21240.061% mcap40.9% of flow
Common Stock
SEC:0001209191-22-035863:0·
018,137 shares0
Common Stock
SEC:0001209191-22-019645:0·
€179,79413,226 shares@ €13.5940.041% mcap27.3% of flow
Common Stock
SEC:0001209191-22-017574:0·
023,516 shares0
Common Stock
SEC:0001209191-22-016780:0·
€36,6812,140 shares@ €17.14080.0083% mcap5.6% of flow
Common Stock
SEC:0001209191-22-010848:0·
€55,3753,119 shares@ €17.7540.012% mcap64.0% of flow
Common Stock
SEC:0001209191-22-003328·
€55,3753,119 shares@ €17.7540.012% mcap8.4% of flow
Common Stock
SEC:0001209191-22-003328:0·
€31,1321,651 shares@ €18.85640.0070% mcap36.0% of flow
Common Stock
SEC:0001209191-21-069773·
€31,1321,651 shares@ €18.85640.0070% mcap4.7% of flow
Common Stock
SEC:0001209191-21-069773:0·
9 of 9 declarations
About HULL CHARLES W
Charles W. Hull is Executive Vice President and Chief Technology Officer (Regenerative Medicine) of 3D Systems Corp. He leads the company's technological initiatives in the field of regenerative medicine, focusing on innovation and the development of new products.
